5d 1m 3m 1y 5y 10y
There is research on this stock available only to PRO subscribers.
There are no Transcripts on BOTA.
GlobeNewswire (Feb 24, 2014)
Biota Pharmaceuticals Reports Second Quarter 2013 Financial Results and Recent Corporate DevelopmentsGlobeNewswire (Feb 10, 2014)
Biota Pharmaceuticals to Host Conference Call to Report Second Quarter Financial Results on February 10, 2014GlobeNewswire (Feb 3, 2014)
GlobeNewswire (Jan 14, 2014)
GlobeNewswire (Jan 10, 2014)
GlobeNewswire (Jan 9, 2014)
GlobeNewswire (Dec 20, 2013)
GlobeNewswire (Dec 5, 2013)
BOTA vs. ETF Alternatives
Monday, Feb 107:11 AM
Monday, Dec 232013, 8:31 AM
Monday, Dec 232013, 8:31 AM| Comment!
- Shares of Biota Pharmaceuticals (BOTA) may see some upside action in Monday's session.
- The company announced Friday that partner Daiichi Sankyo has won Japanese marketing approval for laninamivir octanoate for the prevention of influenza A and B.
- BOTA is developing the treatment outside of Japan. (PR)
Wednesday, Sep 182013, 7:34 AM
Instablogs are blogs which are instantly set up and networked within the Seeking Alpha community. Instablog posts are not selected, edited or screened by Seeking Alpha editors, in contrast to contributors' articles.